⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31327053 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL359603 | 0.97 | — | — | |
| SCHEMBL6072682 | 0.94 | — | — | |
| Cimemoxin SCHEMBL2108333 | 0.91 | — | — | |
| SCHEMBL10079928 | 0.91 | ADH1B (0.48) | — | |
| Hydrochloric Acid SCHEMBL360832 | 0.91 | ADH1B (0.42) | — | |
| SCHEMBL6861640 | 0.91 | ADH1B (0.48) | — | |
| SCHEMBL26584202 | 0.91 | ADH1B (0.48) | — | |
| Cimemoxin SCHEMBL359799 | 0.88 | ADH1B (0.46) | — | |
| Hydrochloric Acid SCHEMBL360226 | 0.88 | ADH1B (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3585500-B1 | INTEGRATED PTSA/MEMBRANE METHOD AND SYSTEM FOR H2S AND CO2 REMOVAL FROM BIOGAS | AIR LIQUIDE ADVANCED TECH US LLC (US) | 2023-08-02 | — | — | EP | disclosed |
| US-11312688-B2 | Pyrazole compound | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2022-04-26 | — | — | US | disclosed |
| US-20200308119-A1 | PYRAZOLE COMPOUND | NEUROINNOVATECH APS (DK) | 2020-10-01 | — | — | US | disclosed |
| US-10723703-B2 | Pyrazole compound | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2020-07-28 | — | — | US | disclosed |
| US-10514610-B2 | Lithography patterning with a gas phase resist | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2019-12-24 | — | — | US | disclosed |
| US-20190351176-A1 | OXYGEN CONCENTRATOR | DAIKIN INDUSTRIES, LTD. (JP) | 2019-11-21 | — | — | US | disclosed |
| US-20190084938-A1 | PYRAZOLE COMPOUND | NEUROINNOVATECH APS (DK) | 2019-03-21 | — | — | US | disclosed |
| US-10183913-B2 | Pyrazole compound | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2019-01-22 | — | — | US | disclosed |
| EP-2986604-B1 | PYRIMIDINE-SUBSTITUTED PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | BOEHRINGER INGELHEIM INT (DE) | 2017-12-20 | — | — | EP | disclosed |
| US-9783477-B2 | Synthesis of fuels and feedstocks | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2017-10-10 | — | — | US | disclosed |
| US-20120080490-A1 | TISSUE THICKNESS COMPENSATOR COMPRISING DETACHABLE PORTIONS | ETHICON ENDO-SURGERY, INC. (US) | 2012-04-05 | — | — | US | disclosed |
| WO-2012008528-A1 | PYRAZOLE COMPOUND | 大日本住友製薬株式会社 (JP) | 2012-01-19 | — | — | WO | disclosed |
| US-7425552-B2 | Antiviral agent especially to treat hepatitis C virus infections; 5-Hydroxy-4-(7-methoxy-1,1-dioxo-1,2-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-py-ridazin-3-one; side effects reduction | ANADYS PHARMACEUTICALS, INC. (US) | 2008-09-16 | — | — | US | disclosed |
| US-7425552-B2 | Antiviral agent especially to treat hepatitis C virus infections; 5-Hydroxy-4-(7-methoxy-1,1-dioxo-1,2-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-py-ridazin-3-one; side effects reduction | ANADYS PHARMACEUTICALS, INC. (US) | 2008-09-16 | — | — | US | disclosed |
| US-7425552-B2 | Antiviral agent especially to treat hepatitis C virus infections; 5-Hydroxy-4-(7-methoxy-1,1-dioxo-1,2-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-py-ridazin-3-one; side effects reduction | ANADYS PHARMACEUTICALS, INC. (US) | 2008-09-16 | — | — | US | disclosed |
| CN-101137651-A | Pyridazinone compounds | ANADYS PHARMACEUTICALS INC (US) | 2008-03-05 | — | — | CN | disclosed |
| EP-1824847-A2 | PYRIDAZINONE COMPOUNDS | Anadys Pharmaceuticals, Inc. (US) | 2007-08-29 | — | — | EP | disclosed |
| US-7205147-B2 | Nucleic acids encoding ryanodine receptors | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-04-17 | — | — | US | disclosed |
| US-20060189602-A1 | Pyridazinone compounds | ANADYS PHARMACEUTICALS, INC. (US) | 2006-08-24 | — | — | US | disclosed |
| WO-2006066079-A2 | PYRIDAZINONE COMPOUNDS | ANADYS PHARMACEUTICALS, INC. (US) | 2006-06-22 | — | — | WO | disclosed |